Dose reduction of biologics in patients with plaque psoriasis: a review

• Үндсэн зохиолчид: C. A. M. van Riel (Зохиогч), C. A. J. Michielsens (Зохиогч), M. E. van Muijen (Зохиогч), L. S. van der Schoot (Зохиогч), J. M. P. A. van den Reek (Зохиогч), E. M. G. J. de Jong (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Dose reduction (DR) of first-generation biologics for plaque psoriasis (TNF-alpha inhibitors (i) and interleukin (IL)-12/23i) has been described in a previous scoping review. The literature on the DR of the newest generation of biologics (IL-17/23i) was scarce. The current review provides a literatu...